Exclusive interview on 2025 physician fee schedule cuts leads November dermatology news

Key takeaways:

• In the top story of November, Healio spoke with an expert on the “catastrophic” impacts the recent CMS cuts will have on patient access.
• FDA news also dominated the month’s headlines.

An in-depth interview about the effects of the CMS’s 2025 physician fee schedule on patient access topped Healio Dermatology’s most-read articles of November, with FDA news also garnering attention.

Here are the top articles from last month.

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. Healio Dermatology spoke with Seemal R. Desai, MD, FAAD, president of the AAD, about why these cuts are being made, how this affects physicians and patients and what dermatologists should do about it. Read more.

‘Another arrow to the quiver for physicians’: FDA approves Emrosi for rosacea

On Nov. 4, the FDA approved Emrosi for the treatment of rosacea in adults. “The approval of Emrosi adds another arrow to the quiver for physicians targeting their patients’ papulopustular rosacea and may be of special interest to patients concerned about antibiotic resistance because of its narrow spectrum of antibiotic activity,” Andrew Huff, president and executive director of the National Rosacea Society, told Healio. Read more.

FDA approves Bimzelx for adults with moderate to severe hidradenitis suppurativa

In the second FDA approval of the month, the agency approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults. Jennifer Hsiao, MD, associate professor of dermatology at Keck School of Medicine of University of Southern California, offered her perspective on the news. Read more.

Speaker talks importance of using correct pronouns for transgender, nonbinary patients

Healio spoke with Anthony Rossi, MD, FAAD, FACMS, assistant attending of dermatologic, Mohs, cosmetic and laser surgery at Memorial Sloan Kettering Cancer Center and founder of Dr. Rossi Derm MD Skincare, about his presentation at the American Society for Dermatologic Surgery Annual Meeting on the importance of dermatologists using correct pronouns when talking to their transgender or nonbinary patients. Read more.

FDA clears first antimicrobial wound dressing with integrated lidocaine for painful wounds

At the beginning of the month, the FDA issued a 510(k) clearance to Imbed Biosciences to market Microlyte Ag/Lidocaine for the management of painful skin wounds. This clearance makes Microlyte Ag/Lidocaine the first antimicrobial wound dressing to integrate lidocaine in this indication. Read more.

Ultrasound device improves aging upper lip appearance

A synchronous ultrasound parallel beam device delivered positive outcomes in perioral rejuvenation, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting. Read more.

Black women report disparities between aesthetic concerns, treatment willingness

A survey found Black women were less likely to seek treatment for certain highly bothersome aesthetic concerns, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting. Read more.

Novel protection, repair skincare regimen with ‘wish list’ ingredients improves photoaging

A novel, six-step skincare regimen comprised of a “wish list” of ingredients improved the signs of photoaging in men and women. Healio spoke with Patricia K. Farris, MD, clinical assistant professor of dermatology at Tulane University School of Medicine, about these findings. Read more.

Poly-L-lactic acid injections stimulate skin rejuvenation over time

Histological evaluations showed poly-L-lactic acid injections stimulate skin rejuvenation over time. Read more.

Hidradenitis suppurativa linked to adverse maternal, offspring outcomes

Hidradenitis suppurativa was linked to adverse maternal and offspring outcomes during the peripartum period and in the long-term. Healio spoke with Nathalie Auger, MD, MSc, clinical professor at the National Institute of Public Health of Quebec in Canada. Read more.